HIGHLIGHTS
- who: Ritu Arora and collaborators from the Mitchell Institute, University of South Alabama, Mobile, AL, USA have published the paper: MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer, in the Journal: Cells 2022, 11, x FOR PEER REVIEW of 14/Dec/2022
- what: The authors report that overexpression of MST4 in results in enhanced cell growth migration and invasion whereas inhibition of MST4 expression significantly attenuates these properties. The authors report an unrecognized function of MST4 for EMT regulation via the MST4-AKT pathway and oncogenic potential of MST4 in breast cancer, together . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.